The U.S. government is demanding that Johnson & Johnson add another $800 million to an initial proposal to settle a federal civil investigation into marketing of the anti-psychotic drug Risperdal, Bloomberg reports.
According to Bloomberg, the Justice Department is demanding that the company pay about $1.8 billion to resolve the civil claims by the U.S. and some states.
The demand came after the Justice Department and states decided a $1 billion settlement that had been negotiated by the U.S. Attorney’s office in ...
continue reading...